First Long Island Investors’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-8,881
Closed -$248K 73
2024
Q2
$248K Buy
+8,881
New +$245K 0.02% 60
2019
Q4
Sell
-390,521
Closed -$13.3M 75
2019
Q3
$13.3M Sell
390,521
-41,147
-10% -$1.5M 1.63% 31
2019
Q2
$17.7M Buy
431,668
+1,511
+0.4% +$60K 2.2% 17
2019
Q1
$17.3M Buy
430,157
+2,375
+0.6% +$95.1K 2.24% 15
2018
Q4
$17.7M Sell
427,782
-4,880
-1% -$203K 2.63% 10
2018
Q3
$18.1M Buy
432,662
+8,795
+2% +$339K 2.34% 14
2018
Q2
$14.6M Sell
423,867
-49,546
-10% -$1.69M 2.08% 19
2018
Q1
$15.9M Buy
473,413
+4,144
+0.9% +$142K 2.2% 15
2017
Q4
$16.1M Buy
469,269
+53,004
+13% +$1.81M 2.19% 19
2017
Q3
$14.1M Buy
416,265
+20,689
+5% +$665K 2.04% 19
2017
Q2
$12.6M Buy
395,576
+54,577
+16% +$1.72M 1.96% 23
2017
Q1
$11.1M Sell
340,999
-361
-0.1% -$11.4K 1.84% 27
2016
Q4
$10.5M Buy
341,360
+15,709
+5% +$480K 1.83% 29
2016
Q3
$10.5M Sell
325,651
-1,400
-0.4% -$46.8K 1.9% 21
2016
Q2
$10.9M Buy
327,051
+7,187
+2% +$229K 2.03% 18
2016
Q1
$8.99M Buy
319,864
+29,138
+10% +$832K 1.72% 37
2015
Q4
$8.9M Sell
290,726
-6,344
-2% -$200K 1.69% 33
2015
Q3
$8.85M Sell
297,070
-5,259
-2% -$169K 1.83% 26
2015
Q2
$9.62M Buy
302,329
+15
+0% +$489 1.87% 19
2015
Q1
$9.98M Buy
302,314
+17,107
+6% +$544K 1.96% 18
2014
Q4
$8.43M Buy
285,207
+8,606
+3% +$247K 1.67% 35
2014
Q3
$7.76M Buy
276,601
+15,715
+6% +$441K 1.69% 36
2014
Q2
$7.35M Buy
260,886
+16,058
+7% +$458K 1.72% 39
2014
Q1
$7.46M Buy
244,828
+2,772
+1% +$82.7K 1.84% 25
2013
Q4
$7.03M Buy
242,056
+6,940
+3% +$202K 1.78% 27
2013
Q3
$6.41M Buy
235,116
+11,320
+5% +$308K 1.8% 29
2013
Q2
$5.95M Buy
+223,796
New +$6.18M 1.88% 26

Other funds holding PFE

First Long Island Investors's PFE Position: Q3 2024 in Review

First Long Island Investors sold out of Pfizer (PFE) in Q3 2024, closing a stake of 8,881 shares — an estimated $248K sold.

First Long Island Investors first reported a position in PFE in Q2 2013 and held it in 27 quarters. The position peaked at $18.1M in Q3 2018. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

  • First Long Island Investors reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
  • First Long Island Investors sold 8,881 Pfizer shares in Q3 2024, an estimated $248K.
  • First Long Island Investors first reported a position in Pfizer in Q2 2013 and held it in 27 quarters.
  • First Long Island Investors's Pfizer position peaked at $18.1M in Q3 2018.
  • 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on First Long Island Investors's 13F filing for Q3 2024, filed 6 Nov 2024.